Brendan P. Teehan
2021
Compensation breakdown
| Non-Equity Incentive Plan | $48,065 |
|---|---|
| Option Awards | $222,643 |
| Salary | $393,917 |
| Stock Awards | $1,765,002 |
| Other | $44,488 |
| Total | $2,474,115 |
Teehan received $1.8M in stock awards, accounting for 71% of the total pay in 2021.
Teehan also received $48.1K in non-equity incentive plan, $222.6K in option awards, $393.9K in salary and $44.5K in other compensation.
Rankings
In 2021, Brendan P. Teehan's compensation ranked 5,190th out of 12,415 executives tracked by ExecPay. In other words, Teehan earned more than 58.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,190 out of 12,415 | 58th |
Division Manufacturing | 2,182 out of 5,505 | 60th |
Major group Chemicals And Allied Products | 943 out of 2,375 | 60th |
Industry group Drugs | 843 out of 2,096 | 60th |
Industry Pharmaceutical Preparations | 606 out of 1,546 | 61st |
Pay ratio
| Brendan P. Teehan's Pay | $2,474,115 |
|---|---|
| Median Employee's Pay | $219,387 |
| Pay Ratio | 11to 1 |
In 2021, the annual total compensation of Brendan P. Teehan was $2,474,115.
The annual total compensation of the median employee at ACADIA Pharmaceuticals was $219,387.
The ratio of Brendan P. Teehan's pay to the pay of median employee was therefore 11 to one.
Teehan's colleagues
We found five more compensation records of executives who worked with Brendan P. Teehan at ACADIA Pharmaceuticals in 2021.
2021
Stephen Davis
ACADIA Pharmaceuticals
Chief Executive Officer
2021
Srdjan Stankovic
ACADIA Pharmaceuticals
President
2021
Mark Schneyer
ACADIA Pharmaceuticals
Chief Financial Officer
2021
Elena Ridloff
ACADIA Pharmaceuticals
Chief Financial Officer
2021
Austin Kim
ACADIA Pharmaceuticals